Study of the impact of Charlson comorbidity index on the ef cacy of adjuvant trastuzumab in patients with HER2 positive early breast cancer


ŞENDUR M. A. N. , AKSOY S., SILAY K. , ÖZDEMİR N., YAZICI o., AKINCI M. B. , ...More

18th ECCO-40th ESMO European Cancer Congress 25-29 September 2015, Vienna, Austria, European Journal of Cancer, Volume 51, Supplement 3, September 2015, S322, 25 - 29 September 2015

  • Publication Type: Conference Paper / Summary Text